Relaxo Footwears (RELAXO) Q2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 24/25 earnings summary
15 Jan, 2026Executive summary
Q2 FY25 revenue from operations was INR 679 crore, down 5% year-over-year due to weak market demand.
PAT for Q2 FY25 was INR 36.7 crore, with margin at 5.4%, impacted by higher depreciation and lower volumes.
EBITDA for Q2 FY25 was INR 88 crore, margin stable at 12.9% versus 12.8% last year.
H1 FY25 revenue was INR 1,428 crore; EBITDA at INR 187 crore, margin at 13.1%.
Unaudited financial results for the quarter and half year ended September 30, 2024, were reviewed and approved by the Board on November 8, 2024.
Financial highlights
Q2 FY25 revenue declined 5% year-over-year to INR 679 crore; H1 FY25 revenue fell 1.8% to INR 1,428 crore.
Q2 FY25 EBITDA was INR 88 crore, down from INR 92 crore last year; PAT was INR 36.7 crore, down from INR 44 crore.
H1 FY25 EBITDA margin at 13.1%, down from 13.7% in H1 FY24.
CapEx of INR 49 crore incurred till 30 September 2024.
Earnings per share (basic and diluted) for H1 FY25 was INR 3.26, compared to INR 4.04 in H1 FY24.
Outlook and guidance
Expecting demand improvement in Q3 due to wedding season.
Volume growth for FY25 expected to be flattish due to H1 decline.
Targeting 8-10% growth in Sparx category; overall revenue growth expected to be positive but cautious.
Margin improvement initiatives ongoing, but FY25 margin guidance revised to around 13% from earlier 15-16%.
Management highlights strong growth potential in the Indian footwear industry, driven by rising disposable income, premiumization, and organized retail expansion.
Latest events from Relaxo Footwears
- Q3FY26 saw stable revenue but lower profit, while FY25 ended with strong cash and growth outlook.RELAXO
Q3 25/2630 Jan 2026 - Q1FY25 revenue up 1.3% year-over-year, but net profit declined as margins contracted.RELAXO
Q1 24/2521 Nov 2025 - Margins stable despite lower sales; growth expected as distribution revamp settles.RELAXO
Q4 24/2521 Nov 2025 - Revenue and profit margins declined, but cash flow and long-term outlook remain strong.RELAXO
Q2 25/2614 Nov 2025 - Q1FY26 profit and EPS rose despite lower revenue, with margin gains and strong cash flow.RELAXO
Q1 25/2631 Jul 2025 - Q3 FY25 revenue and profit fell, but credit ratings and industry outlook remain strong.RELAXO
Q3 24/255 Jun 2025